Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay

BACKGROUND: This study assessed the Granzyme B (GrB) ELISPOT as a viable alternative to the (51)Cr-release assay for measuring cytotoxic activity of innate immune effector cells. We strategically selected the GrB ELISPOT assay because GrB is a hallmark effector molecule of cell-mediated destruction...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafer-Weaver, Kimberly A, Sayers, Thomas, Kuhns, Douglas B, Strobl, Susan L, Burkett, Mark W, Baseler, Michael, Malyguine, Anatoli
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522821/
https://www.ncbi.nlm.nih.gov/pubmed/15380049
http://dx.doi.org/10.1186/1479-5876-2-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522821/
https://www.ncbi.nlm.nih.gov/pubmed/15380049
http://dx.doi.org/10.1186/1479-5876-2-31

Ejemplares similares